JY
CELL

Jeff Yass’s PhenomeX Inc. Common Stock CELL Stock Holding History

Jeff Yass’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-32,454
Closed -$37.6K – 13561
2023
Q1 		$37.6K Sell
32,454
-1,125
-3% -$2.06K ﹤0.01% 11823
2022
Q4 		$90K Buy
33,579
+11,363
+51% +$30K ﹤0.01% 11052
2022
Q3 		$64K Sell
22,216
-20,953
-49% -$89.1K ﹤0.01% 12053
2022
Q2 		$215K Buy
43,169
+6,991
+19% +$36.6K ﹤0.01% 10467
2022
Q1 		$257K Sell
36,178
-60,724
-63% -$502K ﹤0.01% 10652
2021
Q4 		$1.76M Sell
96,902
-29,629
-23% -$639K ﹤0.01% 5805
2021
Q3 		$2.48M Buy
126,531
+29,393
+30% +$1.12M ﹤0.01% 5375
2021
Q2 		$4.35M Sell
97,138
-2,255
-2% -$105K ﹤0.01% 4283
2021
Q1 		$4.99M Buy
99,393
+91,046
+1,091% +$6.21M ﹤0.01% 3917
2020
Q4 		$746K Buy
+8,347
New +$702K ﹤0.01% 7377

Other funds holding CELL

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
NIMC
Nierenberg Investment Management Company Camas, Washington $201M AUM 20.14% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jeff Yass's CELL Position: Q2 2023 in Review

Jeff Yass sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 32,454 shares — an estimated $37.6K sold.

Jeff Yass first reported a position in CELL in Q4 2020 and held it in 10 quarters. The position peaked at $4.99M in Q1 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Jeff Yass reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Jeff Yass sold 32,454 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $37.6K.
  • Jeff Yass first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 10 quarters.
  • Jeff Yass's PhenomeX Inc. Common Stock position peaked at $4.99M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.